SCOPUS 정보 검색 플랫폼

Aging Clinical and Experimental Research

Volumn 25, Issue 5, 2013, Pages 601-603

Rotigotine for anxiety during wearing-off in Parkinson's disease with dementia

(5) Fanciulli, Alessandra a,b Assogna, Francesca c Caltagirone, Carlo c,d Spalletta, Gianfranco c Pontieri, Francesco E a,b,c

a SAPIENZA UNIVERSITY OF ROME (Italy)

b SAPIENZA UNIVERSITY OF ROME (Italy)

c IRCCS FONDAZIONE SANTA LUCIA (Italy)

d UNIVERSITY OF ROME TOR VERGATA (Italy)

Author keywords

Anxiety; Dementia; Non motor symptoms; Parkinson's disease; Rotigotine; Wearing off

Indexed keywords

BENSERAZIDE PLUS LEVODOPA; CARBIDOPA PLUS LEVODOPA; ROTIGOTINE;

AGED; ANXIETY DISORDER; ARTICLE; CASE REPORT; COGNITIVE DEFECT; DEMENTIA; DISEASE SEVERITY; DOPAMINERGIC TRANSMISSION; FEMALE; HUMAN; MOTOR DYSFUNCTION; PARKINSON DISEASE; TREATMENT RESPONSE;

AGED; ANXIETY; DEMENTIA; DOPAMINE AGONISTS; FEMALE; HUMANS; PARKINSON DISEASE; TETRAHYDRONAPHTHALENES; THIOPHENES;

EID: 84886665623 PISSN: 15940667 EISSN: 17208319 Source Type: Journal
DOI: 10.1007/s40520-013-0136-4 Document Type: Article

Times cited : (10)

References (17)

1
- 79451469699
- Intensity-dependent facial emotion recognition and cognitive functions in Parkinson's disease
- 20663240 10.1017/S1355617710000755
- Assogna F, Pontieri FE, Cravello L, Peppe A, Pierantozzi M, Stefani A, Stanzione P, Pellicano C, Caltagirone C, Spalletta G (2010) Intensity-dependent facial emotion recognition and cognitive functions in Parkinson's disease. J Int Neuropsychol Soc 16:867-876
- (2010) J Int Neuropsychol Soc , vol.16 , pp. 867-876
- Assogna, F.¹ Pontieri, F.E.² Cravello, L.³ Peppe, A.⁴ Pierantozzi, M.⁵ Stefani, A.⁶ Stanzione, P.⁷ Pellicano, C.⁸ Caltagirone, C.⁹ Spalletta, G.¹⁰

2
- 35348939603
- Clinical diagnostic criteria for dementia associated with Parkinson's disease
- 17542011 10.1002/mds.21507
- Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, Broe GA, Cummings J, Dickson DW, Gauthier S, Goldman J, Goetz C, Korczyn A, Lees A, Levy R, Litvan I, McKeith I, Olanow W, Poewe W, Quinn N, Sampaio C, Tolosa E, Dubois B (2007) Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord 22:1689-1707
- (2007) Mov Disord , vol.22 , pp. 1689-1707
- Emre, M.¹ Aarsland, D.² Brown, R.³ Burn, D.J.⁴ Duyckaerts, C.⁵ Mizuno, Y.⁶ Broe, G.A.⁷ Cummings, J.⁸ Dickson, D.W.⁹ Gauthier, S.¹⁰ Goldman, J.¹¹ Goetz, C.¹² Korczyn, A.¹³ Lees, A.¹⁴ Levy, R.¹⁵ Litvan, I.¹⁶ McKeith, I.¹⁷ Olanow, W.¹⁸ Poewe, W.¹⁹ Quinn, N.²⁰ more..

3
- 84872331080
- Cognitive impairment in Parkinson's disease: Impact on quality of life, disability, and caregiver burden
- 23172765 10.1177/0891988712464823
- Leroi I, McDonald K, Pantula H, Harbishettar V (2012) Cognitive impairment in Parkinson's disease: impact on quality of life, disability, and caregiver burden. J Geriatr Psychiatry Neurol 25(4):208-214
- (2012) J Geriatr Psychiatry Neurol , vol.25 , Issue.4 , pp. 208-214
- Leroi, I.¹ McDonald, K.² Pantula, H.³ Harbishettar, V.⁴

4
- 33750920501
- End of dose wearing-off in Parkinson's disease: A 9-question survey assessment
- 17095894 10.1097/01.WNF.0000232277.68501.08
- Stacy M, Hauser R, Oertel W, Schapira A, Sethi K, Stocchi F, Tolosa E (2006) End of dose wearing-off in Parkinson's disease: a 9-question survey assessment. Clin Neuropharmacol 29:312-321
- (2006) Clin Neuropharmacol , vol.29 , pp. 312-321
- Stacy, M.¹ Hauser, R.² Oertel, W.³ Schapira, A.⁴ Sethi, K.⁵ Stocchi, F.⁶ Tolosa, E.⁷

5
- 33846425415
- Development of a patient questionnaire to facilitate recognition of motor and non-motor wearing-off in Parkinson's disease
- 16897594 10.1007/s00702-006-0554-y 1:STN:280:DC%2BD2s%2Fjs1Wmtw%3D%3D
- Stacy M, Hauser R (2007) Development of a patient questionnaire to facilitate recognition of motor and non-motor wearing-off in Parkinson's disease. J Neural Transm 114:211-217
- (2007) J Neural Transm , vol.114 , pp. 211-217
- Stacy, M.¹ Hauser, R.²

6
- 0037072288
- Nonmotor fluctuations in Parkinson's disease: Frequent and disabling
- 12177375 10.1212/WNL.59.3.408
- Witjas T, Kaphan E, Azulay JP, Blin O, Ceccaldi M, Pouget J, Poncet M, Chérif AA (2002) Nonmotor fluctuations in Parkinson's disease: frequent and disabling. Neurology 59:408-413
- (2002) Neurology , vol.59 , pp. 408-413
- Witjas, T.¹ Kaphan, E.² Azulay, J.P.³ Blin, O.⁴ Ceccaldi, M.⁵ Pouget, J.⁶ Poncet, M.⁷ Chérif, A.A.⁸

7
- 77954540309
- The wearing-off phenomenon and the use of questionnaires to facilitate its recognition in Parkinson's disease
- 20563826 10.1007/s00702-010-0424-5
- Stacy M (2010) The wearing-off phenomenon and the use of questionnaires to facilitate its recognition in Parkinson's disease. J Neural Transm 117:837-846
- (2010) J Neural Transm , vol.117 , pp. 837-846
- Stacy, M.¹

8
- 73649090347
- Responsiveness of motor and non motor symptoms of Parkinson's disease to dopaminergic therapy
- 19793544 10.1016/j.pnpbp.2009.09.023 1:CAS:528:DC%2BC3cXjvVSgsQ%3D%3D
- Stacy MA, Murck H, Kroenke K (2010) Responsiveness of motor and non motor symptoms of Parkinson's disease to dopaminergic therapy. Prog Neuropsychopharmacol Biol Psychiatry 34:57-61
- (2010) Prog Neuropsychopharmacol Biol Psychiatry , vol.34 , pp. 57-61
- Stacy, M.A.¹ Murck, H.² Kroenke, K.³

9
- 0037018742
- Treatment interventions for Parkinson's disease: An evidence based assessment
- 12047983 10.1016/S0140-6736(02)08520-3
- Rascol O, Goetz C, Koller W, Poewe W, Sampaio C (2002) Treatment interventions for Parkinson's disease: an evidence based assessment. Lancet 359:1589-1598
- (2002) Lancet , vol.359 , pp. 1589-1598
- Rascol, O.¹ Goetz, C.² Koller, W.³ Poewe, W.⁴ Sampaio, C.⁵

10
- 33748929955
- The levodopa wearing-off phenomenon in Parkinson's disease: Pharmacokinetic considerations
- 16805724 10.1517/14656566.7.10.1399 1:CAS:528:DC%2BD28XmslSltL4%3D
- Stocchi F (2006) The levodopa wearing-off phenomenon in Parkinson's disease: pharmacokinetic considerations. Expert Opin Pharmacother 7:1399-1407
- (2006) Expert Opin Pharmacother , vol.7 , pp. 1399-1407
- Stocchi, F.¹

11
- 84855189322
- Continuous drug delivery in early- and late-stage Parkinson's disease as a strategy for avoiding dyskinesia induction and expression
- 21881838 10.1007/s00702-011-0703-9 1:CAS:528:DC%2BC3MXhsFamtrnO
- Jenner P, McCreary AC, Scheller DK (2011) Continuous drug delivery in early- and late-stage Parkinson's disease as a strategy for avoiding dyskinesia induction and expression. J Neural Transm 118:1691-1702
- (2011) J Neural Transm , vol.118 , pp. 1691-1702
- Jenner, P.¹ McCreary, A.C.² Scheller, D.K.³

12
- 79960881173
- Rotigotine transdermal patch: A review of its use in the treatment of Parkinson's disease
- 21790211 10.2165/11206750-000000000-00000 1:CAS:528:DC%2BC3MXht1eqsLfE
- Sanford M, Scott LJ (2011) Rotigotine transdermal patch: a review of its use in the treatment of Parkinson's disease. CNS Drugs 25:699-719
- (2011) CNS Drugs , vol.25 , pp. 699-719
- Sanford, M.¹ Scott, L.J.²

13
- 34249033784
- Transdermal rotigotine: Double-blind, placebo-controlled trial in Parkinson's disease
- 17502466 10.1001/archneur.64.5.676
- Jankovic J, Watts RL, Martin W, Boroojerdi B (2007) Transdermal rotigotine: double-blind, placebo-controlled trial in Parkinson's disease. Arch Neurol 64:676-682
- (2007) Arch Neurol , vol.64 , pp. 676-682
- Jankovic, J.¹ Watts, R.L.² Martin, W.³ Boroojerdi, B.⁴

14
- 34247208187
- Advanced Parkinson disease treated with rotigotine transdermal system: PREFER Study
- SP 650 Study Group 17438216 10.1212/01.wnl.0000259516.61938.bb 1:CAS:528:DC%2BD2sXktFOntLg%3D
- LeWitt PA, Lyons KE, Pahwa R, SP 650 Study Group (2007) Advanced Parkinson disease treated with rotigotine transdermal system: PREFER Study. Neurology 68:1262-1267
- (2007) Neurology , vol.68 , pp. 1262-1267
- Lewitt, P.A.¹ Lyons, K.E.² Pahwa, R.³

15
- 13944273811
- Levodopa challenge neuroimaging of levodopa-related mood fluctuations in Parkinson's disease
- 15602502 10.1038/sj.npp.1300632 1:CAS:528:DC%2BD2MXhtlOrt7s%3D
- Black KJ, Hershey T, Hartlein JM, Cori JL, Perlmutter JS (2005) Levodopa challenge neuroimaging of levodopa-related mood fluctuations in Parkinson's disease. Neuropsychopharmacology 30:590-601
- (2005) Neuropsychopharmacology , vol.30 , pp. 590-601
- Black, K.J.¹ Hershey, T.² Hartlein, J.M.³ Cori, J.L.⁴ Perlmutter, J.S.⁵

16
- 65849303078
- Effects of ropinirole on nonmotor symptoms of Parkinson's disease: A prospective multicenter study
- 18836343 10.1097/WNF.0b013e31815d25ce 1:CAS:528:DC%2BD1cXhtF2ku7fL
- Rektorova I, Balaz M, Svatova J, Zarubova K, Honig I, Dostal V, Sedlackova S, Nestrasil I, Mastik J, Bares M, Veliskova J, Dusek L (2008) Effects of ropinirole on nonmotor symptoms of Parkinson's disease: a prospective multicenter study. Clin Neuropharmacol 31:261-266
- (2008) Clin Neuropharmacol , vol.31 , pp. 261-266
- Rektorova, I.¹ Balaz, M.² Svatova, J.³ Zarubova, K.⁴ Honig, I.⁵ Dostal, V.⁶ Sedlackova, S.⁷ Nestrasil, I.⁸ Mastik, J.⁹ Bares, M.¹⁰ Veliskova, J.¹¹ Dusek, L.¹²

17
- 34248372064
- Efficacy of pramipexole and transdermal rotigotine in advanced Parkinson's disease: A double-blind, double-dummy, randomized controlled trial
- SP 515 Investigators 17509486 10.1016/S1474-4422(07)70108-4 1:CAS:528:DC%2BD2sXmslKktr8%3D
- Poewe WH, Rascol O, Quinn N, Tolosa E, Oertel WH, Martignoni E, Rupp M, Boroojerdi B, SP 515 Investigators (2007) Efficacy of pramipexole and transdermal rotigotine in advanced Parkinson's disease: a double-blind, double-dummy, randomized controlled trial. Lancet Neurol 6:513-520
- (2007) Lancet Neurol , vol.6 , pp. 513-520
- Poewe, W.H.¹ Rascol, O.² Quinn, N.³ Tolosa, E.⁴ Oertel, W.H.⁵ Martignoni, E.⁶ Rupp, M.⁷ Boroojerdi, B.⁸

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.